Sphere 3D Corp
Change company Symbol lookup
Select an option...
ANY Sphere 3D Corp
HMY Harmony Gold Mining Company Ltd
PLX Protalix Biotherapeutics Inc
BEDU Bright Scholar Education Holdings Ltd
USAS Americas Gold and Silver Corporation
AA Alcoa Corp
CRIS Curis Inc
APTO Aptose Biosciences Inc
RGLS Regulus Therapeutics Inc
IMH Impac Mortgage Holdings Inc
Go

Information Technology : Software | Small Cap Value
Based in Canada
Company profile

Sphere 3D Corp is a Canada-based company engaged in software development sector. The Company delivers data management, desktop and application virtualization solutions through hybrid cloud, cloud and on premise implementations by its global reseller network. The Company achieves this through a combination of containerized applications, virtual desktops, virtual storage and physical hyper-converged platforms. The Company’s products allow organizations to deploy a combination of public, private or hybrid cloud strategies while backing them up with the latest storage solutions. The Company has a portfolio of brands including RDX, Glassware 2.0, SnapCLOUD, SnapServer, SnapSync, NEO and V3 .

Closing Price
$2.68
Day's Change
-0.53 (-16.51%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.18
Day's Low
2.40
Volume
(Below Average)
Volume:
19,187,377

10-day average volume:
23,615,748
19,187,377

Transplantation Market to Hit USD 14.67 Billion and Grow at 10.6% CAGR by 2028; Rising Prevalence of Chronic Diseases to Fuel Demand for Organ Transplantation: states Fortune Business Insights(TM)

6:16 am ET March 24, 2021 (Globe Newswire) Print

The global transplantation market size is expected to reach USD 14.67 billion by 2028, exhibiting a CAGR of 10.6% during the forecast period. The rising prevalence of chronic diseases coupled with technological advancements will spur business opportunities for this market, states Fortune Business Insights, in a report, titled "Transplantation Market, 2021-2028." The market size stood at USD 5.47 billion in 2020.

Key Development:

September 2019: CareDx announced a strategic partnership with NanoString to expand its product portfolio. Through this partnership, the company will enhance the development of molecular assays in transplantation and improve transplant diagnostics.

Request a Sample Copy of the Global Research Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/transplantation-market-105049

COVID-19 Impact:

Declined Organ Transplantations to Thwart Market amid Coronavirus

The spread of coronavirus exerted enormous pressure on the healthcare industry, thus restricting the growth of the market. The surging coronavirus cases have compelled governing bodies to postpone elective and non-urgent surgeries in hospitals and ambulatory care centers.

The reduced number of organ donors for organ transplant surgeries due to COVID-19 infection will further dampen the transplantation market growth. For instance, in May 2020, the Italian National Authority for Transplantation released a document guiding that all donor patients must be tested negative for SARS-CoV-2. Potential positive donor organs have to be discarded.

IncreasingGeriatric Population to Stimulate Growth in Asia Pacific

The market in North America is expected to experience steady growth during the forecast period due to the well-developed healthcare infrastructure. The presence of leading players will further augment growth in the region. Moreover, the introduction of novel therapies will bolster the healthy development of the market in North America. Europe is expected to rise exponentially during the forecast period due to the increasing investments in R&D activities.

The large patient population in European countries is expected to promote growth in the region. Asia Pacific is expected to expand radically during the forecast period due to the surging chronic diseases. The increasing geriatric population is expected to enable speedy expansion in Asia Pacific. Latin America, and the Middle East, and Africa are expected to rise sluggishly due to the low adoption of high-cost transplants in the regions.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/transplantation-market-105049

The Tissue Segment to Dominate the Market

Based on product type, the market is classified into tissue products, immunosuppressive drugs, and preservation solutions. The tissue segment is expected to account for the largest due to the advent of new, improved products, including Chondrofix Osteochondral Allograft, DeNovo NT Graft, DuraMatrix Collagen Dura Substitute Membrane. Furthermore, immunosuppressive drugs are expected to experience rapid growth due to the growing adoption of these drugs to prevent post-transplant organ or tissue rejection.

IncreasingGeriatric Population to Stimulate Growth in Asia Pacific

The market in North America is expected to experience steady growth during the forecast period due to the well-developed healthcare infrastructure. The presence of leading players will further augment growth in the region. Moreover, the introduction of novel therapies will bolster the healthy development of the market in North America. Europe is expected to rise exponentially during the forecast period due to the increasing investments in R&D activities.

The large patient population in European countries is expected to promote growth in the region. Asia Pacific is expected to expand radically during the forecast period due to the surging chronic diseases. The increasing geriatric population is expected to enable speedy expansion in Asia Pacific. Latin America, and the Middle East, and Africa are expected to rise sluggishly due to the low adoption of high-cost transplants in the regions.

Quick Buy Transplantation Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/105049

The Report Lists the Key Companies in this Market:

-- Novartis International AG (Basel, Switzerland)

-- AbbVie Inc. (Illinois, U.S)

-- Arthrex, Inc. (Florida, U.S)

-- Biolife Solutions (Washington, U.S)

-- Teva Pharmaceutical (Petah Tikva, Israel)

-- Veloxis Pharmaceuticals, Inc. (Denmark)

-- CareDx. (California, U.S)

-- TransMedics, Inc. (Andover, MA)

-- Other Players

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/transplantation-market-105049

Detailed Table of Content:

-- Introduction

    -- Research Scope

    -- Research Scope

    -- Market Segmentation

    -- Research Methodology

    -- Definitions and Assumptions

    -- Executive Summary

    -- Market Dynamics

      -- Market Drivers

      -- Market Drivers

      -- Market Restraints

      -- Market Opportunities

      -- Key Insights

        -- Number of Major Organ Transplantation, Key Region/Country

        -- Number of Major Organ Transplantation, Key Region/Country

        -- Key Industry Developments- Mergers, Acquisitions and Partnerships

        -- Overview of Regulatory Scenario

        -- Key Industry Trends

        -- Impact of COVID-19 on the Market

        -- Global Transplantation Market Analysis, Insights and Forecast, 2017-2028

          -- Key Findings / Summary

          -- Key Findings / Summary

          -- Market Analysis, Insights and Forecast - By Product Type

            -- Tissue Products

            -- Tissue Products

            -- Immunosuppressive Drugs

            -- Preservation Solutions

            -- Market Analysis, Insights and Forecast - By Application

              -- Organ Transplantation

              -- Organ Transplantation

              -- Tissue Transplantation

              -- Market Analysis, Insights and Forecast - By End-user

                -- Hospitals

                -- Hospitals

                -- Transplantation Centers

                -- Others

                -- Market Analysis, Insights and Forecast - By Country

                  -- North America

                  -- North America

                  -- Europe

                  -- Asia Pacific

                  -- Latin America

                  -- Middle East & Africa

                  -- North America Transplantation Market Analysis, Insights and Forecast, 2017-2028

                    -- Key Findings / Summary

                    -- Key Findings / Summary

                    -- Market Analysis - By Product Type

                      -- Tissue Products

                      -- Tissue Products

                      -- Immunosuppressive Drugs

                      -- Preservation Solutions

                      -- Market Analysis - By Application

                        -- Organ Transplantation

                        -- Organ Transplantation

                        -- Tissue Transplantation

                        -- Market Analysis - By End-user

                          -- Hospitals

                          -- Hospitals

                          -- Transplantation Centers

                          -- Others

                          -- Market Analysis - By Country

                            -- U.S.

                              -- U.S.

                                -- Organ Transplantation

                                -- Tissue Transplantation

                                -- Canada

                                  -- Organ Transplantation

                                  -- Organ Transplantation

                                  -- Tissue Transplantation

                                  TOC Continued....!!!

                                  Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/transplantation-market-105049

                                  Have a Look at Related Reports:

                                  Respiratory Syncytial Virus (RSV) Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Prophylaxis and Treatment), By End-user (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2020-2027

                                  Anxiety Disorders and Depression Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Antidepressants, Anxiolytics, Anticonvulsants, Noradrenergic Agents, and Atypical Antipsychotics), By Indication (Anxiety and Depression), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027

                                  Thin Film Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Type (Oral Thin Film Drugs and Transdermal Thin Film Drugs), By Disease Indication (Schizophrenia, Migraine, Opioid Dependence, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2021-2028

                                  Point-of-Care (POC) Coagulation Testing Devices Market Size, Share & COVID-19 Impact Analysis, By Device Type (Anticoagulation Monitoring Devices (PT-INR, ACT, aPTT), Platelet Function Monitoring Devices, Viscoelastic Coagulation Monitoring Devices (TEG, and ROTEM), and Others); By End User (Hospitals & Clinics, Homecare, and Others), Regional Forecast, 2020-2027

                                  Europe Prothrombin Complex Concentrate (PCC) Market Size, Share & Covid-19 Impact Analysis, By Product (4-factor PCC and 3-factor PCC), By Application (Acquired Coagulation Deficiency and Congenital Coagulation Deficiency and By End User (Hospitals & Ambulatory Surgical Centers, Specialty Clinics, and Others), 2020-2027

                                  About Us:

                                  Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

                                  Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

                                  At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

                                  Contact Us:

                                  Fortune Business Insights(TM) Pvt. Ltd.

                                  308, Supreme Headquarters,

                                  Survey No. 36, Baner,

                                  Pune-Bangalore Highway,

                                  Pune - 411045, Maharashtra, India.

                                  Phone:

                                  US :+1 424 253 0390

                                  UK : +44 2071 939123

                                  APAC : +91 744 740 1245

                                  Email: sales@fortunebusinessinsights.com

                                  Fortune Business Insights(TM)

                                  LinkedIn | Twitter | Blogs

                                  https://ml.globenewswire.com/media/05408ba1-26b1-4fdd-8f48-1af4df373348/small/fbi-logo-tm-png.png

                                  https://ml.globenewswire.com/media/05408ba1-26b1-4fdd-8f48-1af4df373348/small/fbi-logo-tm-png.png

                                  comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.